Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
New Financing Models May Expand Access to Life-Changing Cell and Gene Therapies
Featured Experts: Alison Sexton Ward, Elizabeth Fowler, Jeremy L. Shane, Darius Lakdawalla
In The News View All
NBC News
Joyce explains how TrumpRx could better serve consumers
Featured Experts: Geoffrey Joyce
The New York Times
New York Times cites Schaeffer research on how TV drug ads could benefit consumers
Stateline
Insurer formularies often favor opioid pain medications over non-opioid alternatives, Qato explains
Featured Experts: Dima M. Qato
Los Angeles Times
USC Schaeffer scholars quoted on the rollout of TrumpRx
Featured Experts: Geoffrey Joyce, Darius Lakdawalla
Bloomberg
Lakdawalla argues for a drug pricing system aligned with American values
Featured Experts: Darius Lakdawalla
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
